Companies & People
Liquidia agrees to $380.7 million settlement, narrows YUTREPIA market
MORRISVILLE — Liquidia agreed to pay a net $380.7 million to settle six lawsuits with United Therapeutics, preserving YUTREPIA sales for pulmonary arterial hypertension while withdrawing YUTREPIA from…